A2 Milk shares jump 12% on strong half-year result and guidance upgrade

This infant formula company impressed with its results on Monday.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a2 Milk Company Ltd (ASX: A2M) shares are starting the week on a very positive note.

In morning trade, the infant formula company's shares are up 12.5% to $9.60.

Investors have been buying its shares after it delivered strong first-half growth and upgraded its full-year outlook.

Smiling young parents with their daughter dream of success.

Images source: Getty Images

A2 Milk shares jump on results day

For the six months ended 31 December, a2 Milk reported revenue of NZ$993.5 million, up 18.8% on the prior corresponding period.

Management notes that this was driven by strong performances across all segments and product categories, with growth primarily from core products supported by recent innovation.

Total infant milk formula (IMF) sales increased 13.6%, underpinned by continued brand strength and solid execution across channels. Liquid milk sales rose 18.5%, while Other Nutritionals revenue surged 42.9% (excluding a2 Pokeno ingredient sales).

Also growing strongly was its underlying EBITDA, which rose 25.9% to NZ$164.8 million, while underlying net profit after tax increased 19.6% to NZ$122.6 million. On a statutory basis, net profit after tax rose 9.4% to NZ$112.1 million.

The board declared an interim dividend of 11.5 NZ cents per share, up 35.3% year on year, representing around 74% of net profit from continuing operations.

Management commentary

A2 Milk's managing director and CEO, David Bortolussi, was pleased with the half. He said:

We continue to execute our growth strategy with a focus on maximising opportunities in China infant milk formula, adjacent categories and new markets.

Infant milk formula remains central to our growth strategy and continues to outperform the China market, delivering 13.6% year-on-year revenue growth. Our liquid milk businesses continue to perform exceptionally well in Australia and the US, with both achieving double-digit revenue growth as more consumers embrace the benefits of a2 Milk.

The Company's strong performance in the half has enabled us to upgrade our FY26 full year guidance and declare an interim dividend at the higher end of our policy range.

Outlook

As mentioned above, A2 Milk has upgraded its FY 2026 guidance following a stronger than expected first half.

The company now expects revenue growth in the mid double-digit percentage range (from low double-digit) compared to FY 2025 continuing operations. EBITDA margin is forecast to be approximately 15.5% to 16.0%, with net profit expected to be up on FY 2025 reported levels.

Bortolussi adds:

Our upgraded outlook means we are now on track to achieve our $2 billion medium term sales ambition in FY26, a full year ahead of plan. This is testament to the execution of our team and the strength of the a2 brand.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

Doctor doing a telemedicine using laptop at a medical clinic
Earnings Results

Guess which ASX 200 stock is jumping 9% on FY26 results

This medical device company has released its FY 2026 results. Let's see what it reported.

Read more »

A man sitting in an aeroplane seat holds the top of his head as he looks at his airline ticket with an annoyed, angry expression on his face.
Earnings Results

Webjet shares crash 15% as Virgin Australia blow hits outlook

Webjet shares are under heavy pressure after its latest update.

Read more »

A man sitting at his desktop computer leans forward onto his elbows and yawns while he rubs his eyes as though he is very tired.
Earnings Results

James Hardie shares tumble on FY26 profit crunch

Investors have been hitting the sell button on Wednesday. Let's find out why.

Read more »

a man in a green and gold Australian athletic kit roars ecstatically with a wide open mouth while his hands are clenched and raised as a shower of gold confetti falls in the sky around him.
Earnings Results

Why are Catapult Sport shares jumping 18% today?

This sports technology company has delivered a stronger than expected FY 2026 result.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Earnings Results

Which ASX 200 share is crashing 22% on half-year results?

Let's see why investors are hitting the sell button on Monday.

Read more »

A man in a suit looks surprised as he looks through binoculars.
Earnings Results

Guess which ASX 200 stock is dropping despite record quarterly profit

It was a record-breaking quarter for this company.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Earnings Results

Why Xero shares are falling despite a big jump in revenue

Xero shares are under pressure as Melio costs weigh on profit.

Read more »

A man looking at his laptop and thinking.
Earnings Results

ASX 200 stock crashes 12% on half-year results

Profit is down but its guidance has been reaffirmed.

Read more »